Overview

Haloperidol for Pain Control in Patients With Acute Musculoskeletal Back Pain in the Emergency Department

Status:
RECRUITING
Trial end date:
2027-04-15
Target enrollment:
Participant gender:
Summary
Single center, double-blind, randomized, controlled trial in patients who present to the emergency department (ED) with a chief complaint of back pain. A total of 150 patients age 18-65 presenting to the emergency department with chief complaint of backpain will be enrolled from April 2024 - April 2025. Patients will be randomized and symptom levels will be recorded at 30, 60, 90, minutes. Follow-up will be performed by telephone at 24 hours.
Phase:
PHASE4
Details
Lead Sponsor:
Western Michigan University School of Medicine
Collaborator:
Bronson Methodist Hospital
Treatments:
Haloperidol
Ketorolac Tromethamine